Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa)
- PMID: 12676044
- DOI: 10.1089/107555303321223035
Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa)
Abstract
Introduction: Tumeric is a spice that comes from the root Curcuma longa, a member of the ginger family, Zingaberaceae. In Ayurveda (Indian traditional medicine), tumeric has been used for its medicinal properties for various indications and through different routes of administration, including topically, orally, and by inhalation. Curcuminoids are components of tumeric, which include mainly curcumin (diferuloyl methane), demethoxycurcumin, and bisdemethoxycurcmin.
Objectives: The goal of this systematic review of the literature was to summarize the literature on the safety and anti-inflammatory activity of curcumin.
Methods: A search of the computerized database MEDLINE (1966 to January 2002), a manual search of bibliographies of papers identified through MEDLINE, and an Internet search using multiple search engines for references on this topic was conducted. The PDR for Herbal Medicines, and four textbooks on herbal medicine and their bibliographies were also searched.
Results: A large number of studies on curcumin were identified. These included studies on the antioxidant, anti-inflammatory, antiviral, and antifungal properties of curcuminoids. Studies on the toxicity and anti-inflammatory properties of curcumin have included in vitro, animal, and human studies. A phase 1 human trial with 25 subjects using up to 8000 mg of curcumin per day for 3 months found no toxicity from curcumin. Five other human trials using 1125-2500 mg of curcumin per day have also found it to be safe. These human studies have found some evidence of anti-inflammatory activity of curcumin. The laboratory studies have identified a number of different molecules involved in inflammation that are inhibited by curcumin including phospholipase, lipooxygenase, cyclooxygenase 2, leukotrienes, thromboxane, prostaglandins, nitric oxide, collagenase, elastase, hyaluronidase, monocyte chemoattractant protein-1 (MCP-1), interferon-inducible protein, tumor necrosis factor (TNF), and interleukin-12 (IL-12).
Conclusions: Curcumin has been demonstrated to be safe in six human trials and has demonstrated anti-inflammatory activity. It may exert its anti-inflammatory activity by inhibition of a number of different molecules that play a role in inflammation.
Similar articles
-
Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review.Biofactors. 2021 May;47(3):311-350. doi: 10.1002/biof.1716. Epub 2021 Feb 19. Biofactors. 2021. PMID: 33606322 Review.
-
From medicinal plant extracts to defined chemical compounds targeting the histamine H4 receptor: Curcuma longa in the treatment of inflammation.Inflamm Res. 2017 Oct;66(10):923-929. doi: 10.1007/s00011-017-1075-x. Epub 2017 Jun 24. Inflamm Res. 2017. PMID: 28647836
-
Curcumin as a natural regulator of monocyte chemoattractant protein-1.Cytokine Growth Factor Rev. 2017 Feb;33:55-63. doi: 10.1016/j.cytogfr.2016.10.001. Epub 2016 Oct 8. Cytokine Growth Factor Rev. 2017. PMID: 27743775 Review.
-
Curcumin: the Indian solid gold.Adv Exp Med Biol. 2007;595:1-75. doi: 10.1007/978-0-387-46401-5_1. Adv Exp Med Biol. 2007. PMID: 17569205 Review.
-
Biological activities of Curcuma longa L.Mem Inst Oswaldo Cruz. 2001 Jul;96(5):723-8. doi: 10.1590/s0074-02762001000500026. Mem Inst Oswaldo Cruz. 2001. PMID: 11500779 Review.
Cited by
-
An Overview of the Spices Used for the Prevention and Potential Treatment of Gastric Cancer.Cancers (Basel). 2024 Apr 22;16(8):1611. doi: 10.3390/cancers16081611. Cancers (Basel). 2024. PMID: 38672692 Free PMC article. Review.
-
Therapeutic effect of curcumin nanoemulsion on cystic echinococcosis in BALB/c mice: a computerized tomography (CT) scan and histopathologic study evaluation.BMC Complement Med Ther. 2024 Apr 4;24(1):143. doi: 10.1186/s12906-024-04451-z. BMC Complement Med Ther. 2024. PMID: 38575891 Free PMC article.
-
Anti-gouty arthritis and anti-inflammatory effects of curcumin nanoparticles in monosodium urate crystals induced Balb/C mice.Inflammopharmacology. 2024 Jun;32(3):1929-1940. doi: 10.1007/s10787-024-01450-x. Epub 2024 Mar 31. Inflammopharmacology. 2024. PMID: 38556563
-
Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment.Antioxidants (Basel). 2024 Mar 8;13(3):331. doi: 10.3390/antiox13030331. Antioxidants (Basel). 2024. PMID: 38539864 Free PMC article. Review.
-
Assessment of the Efficiency of Tulsi Extract as a Locally Administered Medication Agent and Its Comparison With Curcumin in the Treatment of Periodontal Pockets.Cureus. 2024 Feb 21;16(2):e54619. doi: 10.7759/cureus.54619. eCollection 2024 Feb. Cureus. 2024. PMID: 38523946 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous